查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1447150

到 2030 年經皮給藥系統市場預測：按產品類型、組件、技術、應用、最終用戶和地區進行的全球分析

Transdermal Drug Delivery Systems Market Forecasts to 2030 - Global Analysis By Product Type (Transdermal Patches, Gels, Sprays, Microneedles, Iontophoresis Systems & Other Product Types), Component, Technology, Application, End User & By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2023年全球經皮給藥系統市場規模將達662億美元，預計2030年將達到1,646億美元，預測期內年複合成長率為13.9%。

經經皮給藥系統透過皮膚給藥，提供一種非侵入性和受控的方法。經經皮給藥系統利用含有緩慢吸收到血流中的藥物製劑的貼片。皮膚的外層角質層可作為屏障並調節藥物釋放。這種方法可以最大限度地減少副作用，提高患者的依從性並穩定藥物濃度。

根據世界神經病學聯合會2023年報告，神經系統疾病現已成為全球第二大死因和第一大殘疾原因。全球疾病負擔 (GBD) 研究預測，到 2050 年，患有腦部疾病的人數將增加一倍。

慢性病增加

隨著糖尿病、心血管疾病和慢性疼痛的流行，TDDS 因其方便性、藥物緩釋和提高患者依從性而成為首選解決方案。隨著長期用藥需求的不斷增加，TDDS 可以實現非侵入性且使用者友好的給藥方式。這一趨勢正在推動市場成長，推動藥物創新，擴大經皮吸收貼片的治療範圍，並為有效的慢性病管理創造一個充滿活力的前景。

合適的藥物有限

某些藥物的固有特性，例如分子大小、親油性和電荷，限制了有效的經皮給藥。這項限制縮小了應用範圍並阻礙了市場成長。製藥業的進步對於增加與 TDDS 相容的藥物種類至關重要。克服這一限制對於充分發揮經皮給藥的潛力以提供一種非侵入性且對患者友好的替代方案至關重要，特別是對於對慢性病管理至關重要的藥物至關重要。

對非侵入性藥物輸送的需求不斷成長

隨著患者尋求方便且無痛的替代方案，經皮吸收貼片透過皮膚輸送藥物提供了一種有吸引力的解決方案。這種方法提高了患者的依從性和舒適度，特別是對於需要長期治療的慢性病。經經皮給藥對於滿足醫療保健需求非常重要，因為人們對非侵入性選擇的偏好不斷增加，減少與針頭相關的焦慮並改善整體治療體驗的願望推動了他被定位為一個強大的參與者。

開發和監管成本高

複雜而嚴格的監管要求，加上龐大的研發成本，為公司帶來了經濟障礙。這些成本會抑制投資和創新，並限制新的經皮製劑的推出。因此，市場成長可能會放緩，先進經皮製劑技術的取得可能會減少。

COVID-19 的影響

供應鏈中斷、醫療就診減少以及對抗疫情的資源轉移正在影響市場成長。然而，對非侵入性藥物傳遞方法的需求以及對家庭治療的關注導致人們對經皮系統的興趣增加。該行業正在適應應對遠端患者監測和提高經皮功效等挑戰。這場流行病加速了該領域的創新和研究，隨著醫療保健需求和偏好的變化，增強了韌性和未來的成長潛力。

在預測期內，經皮貼片製劑領域預計將是最大的。

由於易於使用、副作用減少以及貼片相關合規性的提高，經皮貼片正在推動市場成長。經皮吸收貼片具有控制藥物釋放、持續治療水準和最小化變異性等優點。這導致患者和醫療保健提供者的接受度提高。此外，隨著技術進步解決挑戰並為創新應用鋪平道路，以及標誌著向更高效和以患者為中心的藥物輸送解決方案的持續轉變，經皮藥物輸送系統市場必將擴大。

預計疼痛管理產業在預測期內年複合成長率最高

預計疼痛管理領域在預測期內年複合成長率最高。這是因為對方便且患者友好的替代品的需求正在促進市場擴張。此外，創新配方和技術的發展提高了經皮給藥的有效性，使其成為疼痛管理的有吸引力的選擇。隨著醫療保健提供者優先考慮更安全、更容易獲得的疼痛治療，經皮給藥系統市場預計將持續成長。

比最大的地區

由於有利的報銷方案和政府組織意識的提高等因素，預計亞太地區將在預測期內佔據最大的市場佔有率，從而促進該地區經皮給藥系統市場的成長。隨著醫療保健結構的發展足以支付公民的醫療費用，越來越多的人選擇在該地區尋求治療。預計這將進一步推動預測期內的市場成長。

年複合成長率最高的地區：

由於醫療基礎設施、技術進步以及對製藥業研發的日益關注，預計北美在預測期內將出現最高的年複合成長率。此外，該國慢性病的高盛行率和人口老化正在增加對經皮吸收貼片創新給藥系統的需求。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球經皮給藥系統市場：依產品類型

  • 經皮吸收貼片
  • 凝膠
  • 噴
  • 微型針
  • 離子導入系統
  • 其他產品類型

第6章全球經皮給藥系統市場：依組成部分

  • 控制膜
  • 藥物儲存
  • 微儲庫陣列
  • 黏劑系統
  • 滲透促進劑
  • 載體系統

第7章全球經皮給藥系統市場：依技術分類

  • 矩陣系統
  • 電穿孔
  • 超音波介紹
  • 噴射注射器
  • 微米和奈米技術

第8章全球經皮給藥系統市場：依應用分類

  • 疼痛管理
  • 荷爾蒙補充療法（HRT）
  • 心血管疾病
  • 中樞神經系統疾病
  • 禁止抽煙
  • 糖尿病
  • 其他用途

第9章全球經皮給藥系統市場：依最終使用者分類

  • 醫院和診所
  • 門診手術中心
  • 研究和學術機構
  • 製藥公司
  • 獸醫護理
  • 其他最終用戶

第10章全球經皮給藥系統市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Johnson & Johnson
  • Novartis AG
  • Boehringer Ingelheim GmbH
  • Mylan Pharmaceuticals, Inc.
  • 3M Company
  • Noven Pharmaceuticals, Inc.
  • Grunenthal
  • 4P Therapeutics, LLC
  • AbbVie
  • Hisamitsu Pharmaceutical co. Inc
  • Endo International
  • Purdue Pharma
  • GlaxoSmithKline
  • UCB
  • Viatris Inc.
  • Styker
  • Grifols
  • Amgen
  • Lubrizol Corporation
  • AdhexPharma
Product Code: SMRC25411

According to Stratistics MRC, the Global Transdermal Drug Delivery Systems Market is accounted for $66.2 billion in 2023 and is expected to reach $164.6 billion by 2030 growing at a CAGR of 13.9% during the forecast period. Transdermal drug delivery systems administer medications through the skin, providing a non-invasive and controlled approach. They utilize patches containing drug formulations, allowing gradual absorption into the bloodstream. The skin's outer layer, the stratum corneum, acts as a barrier, regulating drug release. This method minimizes side effects, enhances patient compliance, and maintains steady drug levels.

According to the World Federation of Neurology's 2023 report, neurological disorders currently rank as the second highest cause of death and the primary cause of disability worldwide. A Global Burden of Disease (GBD) study forecasts a doubling of individuals living with brain diseases by 2050.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

As diabetes, cardiovascular conditions, and chronic pain become more widespread, TDDS emerges as a preferred solution due to its convenience, sustained drug release, and improved patient compliance. The rising need for long-term medication adherence aligns with TDDS's ability to offer non-invasive, user-friendly administration. This trend propels market growth, encouraging pharmaceutical innovation and expanding the scope of transdermal patches into diverse therapeutic areas, creating a dynamic landscape for effective chronic disease management.

Restraint:

Limited range of suitable drugs

The inherent characteristics of certain medications, such as molecular size, lipophilicity, and charge, restrict their effective transdermal delivery. This limitation narrows the scope of applications, hindering the market's growth potential. Pharmaceutical advancements are essential to expand the repertoire of drugs compatible with TDDS. Overcoming this constraint is crucial for realizing the full potential of transdermal delivery in offering non-invasive and patient-friendly alternatives, especially for medications crucial in managing chronic conditions.

Opportunity:

Increasing demand for non-invasive drug delivery

As patients seek convenient, painless alternatives, transdermal patches offer an attractive solution by delivering medications through the skin. This approach enhances patient compliance and comfort, particularly for chronic conditions requiring prolonged treatment. The growing preference for non-invasive options, driven by the desire to reduce needle-related anxieties and improve overall treatment experience, positions transdermal drug delivery as a key player in meeting healthcare demands.

Threat:

High development and regulatory costs

The complex and stringent regulatory requirements, coupled with extensive research and development expenses, create financial barriers for companies. These costs may deter investment and innovation, limiting the introduction of novel transdermal formulations. Consequently, the market may experience slower growth and reduced accessibility to advanced transdermal technologies.

Covid-19 Impact

Supply chain disruptions, reduced healthcare visits, and diverted resources towards pandemic management have affected market growth. However, the demand for non-invasive drug delivery methods and the focus on home-based treatments have increased interest in transdermal systems. The industry is adapting to address challenges, such as remote patient monitoring and enhancing the efficacy of transdermal drug delivery. The pandemic has accelerated innovation and research in this sector, fostering resilience and potential future growth in the context of evolving healthcare needs and preferences.

The transdermal patches segment is expected to be the largest during the forecast period

The transdermal patches segment is estimated to have a lucrative growth, due to the ease of use, reduced side effects, and improved compliance associated with patches have driven market growth. They offer advantages like controlled drug release, sustained therapeutic levels, and minimized fluctuations. This has led to increased acceptance among patients and healthcare providers. Moreover the Transdermal Drug Delivery Systems market continues to expand as technological advancements address challenges and pave the way for innovative applications, demonstrating a shift towards more efficient, patient-centric drug delivery solutions.

The pain management segment is expected to have the highest CAGR during the forecast period

The pain management segment is anticipated to witness the highest CAGR growth during the forecast period, owing to the demand for a convenient and patient-friendly alternative contributes to the market expansion. Additionally, the development of innovative formulations and technologies enhances the efficacy of transdermal drug delivery, making it an attractive option for pain management. As healthcare providers prioritize safer and more accessible pain therapies, the market for transdermal drug delivery systems is poised to experience continued growth.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the factors such as favourable reimbursement scenarios and rising awareness by government organizations contribute to the region's transdermal drug delivery system market growth. A well-developed healthcare structure covering the citizens' healthcare costs promotes more people opting for treatment in the region. This is expected further to boost the market growth over the forecast period.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, due to its access to healthcare infrastructure, technological advancements, and a substantial focus on research and development within the pharmaceutical industry. Additionally, a higher prevalence of chronic diseases and an aging population in the country have fueled the demand for innovative drug delivery systems like transdermal patches.

Key players in the market

Some of the key players in the Transdermal Drug Delivery Systems Market include Johnson & Johnson, Novartis AG, Boehringer Ingelheim GmbH, Mylan Pharmaceuticals, Inc., 3M Company, Noven Pharmaceuticals, Inc., Grunenthal, 4P Therapeutics, LLC, AbbVie, Hisamitsu Pharmaceutical co. Inc, Endo International, Purdue Pharma, GlaxoSmithKline, UCB , Viatris Inc., Styker, Grifols, Amgen, Lubrizol Corporation and AdhexPharma

Key Developments:

In February 2024, Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cash. The acquisition, which is subject to customary closing conditions, including a minimum acceptance threshold of 65% of outstanding shares tendered in the takeover offer and regulatory approvals

In January 2024, Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer. In addition, Ambrx's pipeline and ADC platform present exciting future opportunities to deliver enhanced, precision biologics as transform the treatment of cancer and improve patients' lives.

In January 2024, CERENOVUS Launches Next Generation Catheter for Revascularization of Patients with Acute Ischemic Stroke and is optimized for effective direct aspiration and for the delivery of compatible stent retrievers,iii including the EMBOTRAP(TM) III Revascularization Device, into the neurovasculature.

Product Types Covered:

  • Transdermal Patches
  • Gels
  • Sprays
  • Microneedles
  • Iontophoresis Systems
  • Other Product Types

Components Covered:

  • Controlled Membrane
  • Drug Reservoir
  • Micro-Reservoir Arrays
  • Adhesive System
  • Permeation Enhancers
  • Carrier Systems

Technologies Covered:

  • Matrix Systems
  • Electroporation
  • Sonophoresis
  • Jet Injectors
  • Micro- and Nano-Technology

Applications Covered:

  • Pain Management
  • Hormone Replacement Therapy (HRT)
  • Cardiovascular Disorders
  • Central Nervous System Disorders
  • Smoking Cessation
  • Diabetes
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Research & Academic Institutes
  • Pharmaceutical Companies
  • Veterinary Care
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transdermal Drug Delivery Systems Market, By Product Type

  • 5.1 Introduction
  • 5.2 Transdermal Patches
  • 5.3 Gels
  • 5.4 Sprays
  • 5.5 Microneedles
  • 5.6 Iontophoresis Systems
  • 5.7 Other Product Types

6 Global Transdermal Drug Delivery Systems Market, By Component

  • 6.1 Introduction
  • 6.2 Controlled Membrane
  • 6.3 Drug Reservoir
  • 6.4 Micro-Reservoir Arrays
  • 6.5 Adhesive System
  • 6.6 Permeation Enhancers
  • 6.7 Carrier Systems

7 Global Transdermal Drug Delivery Systems Market, By Technology

  • 7.1 Introduction
  • 7.2 Matrix Systems
  • 7.3 Electroporation
  • 7.4 Sonophoresis
  • 7.5 Jet Injectors
  • 7.6 Micro- and Nano-Technology

8 Global Transdermal Drug Delivery Systems Market, By Application

  • 8.1 Introduction
  • 8.2 Pain Management
  • 8.3 Hormone Replacement Therapy (HRT)
  • 8.4 Cardiovascular Disorders
  • 8.5 Central Nervous System Disorders
  • 8.6 Smoking Cessation
  • 8.7 Diabetes
  • 8.8 Other Applications

9 Global Transdermal Drug Delivery Systems Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Ambulatory Surgical Centers
  • 9.4 Research & Academic Institutes
  • 9.5 Pharmaceutical Companies
  • 9.6 Veterinary Care
  • 9.7 Other End Users

10 Global Transdermal Drug Delivery Systems Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Johnson & Johnson
  • 12.2 Novartis AG
  • 12.3 Boehringer Ingelheim GmbH
  • 12.4 Mylan Pharmaceuticals, Inc.
  • 12.5 3M Company
  • 12.6 Noven Pharmaceuticals, Inc.
  • 12.7 Grunenthal
  • 12.8 4P Therapeutics, LLC
  • 12.9 AbbVie
  • 12.10 Hisamitsu Pharmaceutical co. Inc
  • 12.11 Endo International
  • 12.12 Purdue Pharma
  • 12.13 GlaxoSmithKline
  • 12.14 UCB
  • 12.15 Viatris Inc.
  • 12.16 Styker
  • 12.17 Grifols
  • 12.18 Amgen
  • 12.19 Lubrizol Corporation
  • 12.20 AdhexPharma

List of Tables

  • Table 1 Global Transdermal Drug Delivery Systems Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Transdermal Drug Delivery Systems Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Transdermal Drug Delivery Systems Market Outlook, By Transdermal Patches (2021-2030) ($MN)
  • Table 4 Global Transdermal Drug Delivery Systems Market Outlook, By Gels (2021-2030) ($MN)
  • Table 5 Global Transdermal Drug Delivery Systems Market Outlook, By Sprays (2021-2030) ($MN)
  • Table 6 Global Transdermal Drug Delivery Systems Market Outlook, By Microneedles (2021-2030) ($MN)
  • Table 7 Global Transdermal Drug Delivery Systems Market Outlook, By Iontophoresis Systems (2021-2030) ($MN)
  • Table 8 Global Transdermal Drug Delivery Systems Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 9 Global Transdermal Drug Delivery Systems Market Outlook, By Component (2021-2030) ($MN)
  • Table 10 Global Transdermal Drug Delivery Systems Market Outlook, By Controlled Membrane (2021-2030) ($MN)
  • Table 11 Global Transdermal Drug Delivery Systems Market Outlook, By Drug Reservoir (2021-2030) ($MN)
  • Table 12 Global Transdermal Drug Delivery Systems Market Outlook, By Micro-Reservoir Arrays (2021-2030) ($MN)
  • Table 13 Global Transdermal Drug Delivery Systems Market Outlook, By Adhesive System (2021-2030) ($MN)
  • Table 14 Global Transdermal Drug Delivery Systems Market Outlook, By Permeation Enhancers (2021-2030) ($MN)
  • Table 15 Global Transdermal Drug Delivery Systems Market Outlook, By Carrier Systems (2021-2030) ($MN)
  • Table 16 Global Transdermal Drug Delivery Systems Market Outlook, By Technology (2021-2030) ($MN)
  • Table 17 Global Transdermal Drug Delivery Systems Market Outlook, By Matrix Systems (2021-2030) ($MN)
  • Table 18 Global Transdermal Drug Delivery Systems Market Outlook, By Electroporation (2021-2030) ($MN)
  • Table 19 Global Transdermal Drug Delivery Systems Market Outlook, By Sonophoresis (2021-2030) ($MN)
  • Table 20 Global Transdermal Drug Delivery Systems Market Outlook, By Jet Injectors (2021-2030) ($MN)
  • Table 21 Global Transdermal Drug Delivery Systems Market Outlook, By Micro- and Nano-Technology (2021-2030) ($MN)
  • Table 22 Global Transdermal Drug Delivery Systems Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 Global Transdermal Drug Delivery Systems Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 24 Global Transdermal Drug Delivery Systems Market Outlook, By Hormone Replacement Therapy (HRT) (2021-2030) ($MN)
  • Table 25 Global Transdermal Drug Delivery Systems Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 26 Global Transdermal Drug Delivery Systems Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 27 Global Transdermal Drug Delivery Systems Market Outlook, By Smoking Cessation (2021-2030) ($MN)
  • Table 28 Global Transdermal Drug Delivery Systems Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 29 Global Transdermal Drug Delivery Systems Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 30 Global Transdermal Drug Delivery Systems Market Outlook, By End User (2021-2030) ($MN)
  • Table 31 Global Transdermal Drug Delivery Systems Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 32 Global Transdermal Drug Delivery Systems Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 33 Global Transdermal Drug Delivery Systems Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 34 Global Transdermal Drug Delivery Systems Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 35 Global Transdermal Drug Delivery Systems Market Outlook, By Veterinary Care (2021-2030) ($MN)
  • Table 36 Global Transdermal Drug Delivery Systems Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.